BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Amneal Pharmaceuticals received Food and Drug Administration approval for its albuterol sulfate inhalation aerosol to treat bronchospasm in people with reversible obstructive airway disease. The ...
Albuterol sulfate inhalation aerosol is indicated for the treatment or prevention of bronchospasm in adults and children 12 years of age and older with reversible obstructive airway disease. Kone ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. GlaxoSmithKline ( (GB:GSK)) has provided ...
Democratic U.S. Senator Maggie Hassan has reportedly launched an investigation into British pharmaceutical giant GSK's (NYSE:GSK) decision to pull the branded Flovent HFA asthma inhaler from the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback